BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25053544)

  • 1. Gastric neuroendocrine neoplasms and related precursor lesions.
    La Rosa S; Vanoli A
    J Clin Pathol; 2014 Nov; 67(11):938-48. PubMed ID: 25053544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Republished: gastric neuroendocrine neoplasms and related precursor lesions.
    La Rosa S; Vanoli A
    Postgrad Med J; 2015 Mar; 91(1073):163-73. PubMed ID: 25740317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
    Solcia E; Rindi G; Larosa S; Capella C
    Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
    Vanoli A; La Rosa S; Luinetti O; Klersy C; Manca R; Alvisi C; Rossi S; Trespi E; Zangrandi A; Sessa F; Capella C; Solcia E
    Hum Pathol; 2013 Sep; 44(9):1827-37. PubMed ID: 23642738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors.
    Klöppel G; Anlauf M; Perren A
    Endocr Pathol; 2007; 18(3):150-5. PubMed ID: 18058264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
    Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E
    Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic aspects of gastric neuroendocrine tumors.
    Rindi G
    Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ODF1 in Gastrointestinal Tract Neuroendocrine Neoplasms: a Novel Potential Immunohistochemical Biomarker for Well-differentiated Neuroendocrine Tumors.
    Li B; Li X; Mao R; Liu M; Fu L; Shi L; Zhao S; Fu M
    Endocr Pathol; 2021 Jun; 32(2):301-308. PubMed ID: 32869188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms.
    La Rosa S; Inzani F; Vanoli A; Klersy C; Dainese L; Rindi G; Capella C; Bordi C; Solcia E
    Hum Pathol; 2011 Oct; 42(10):1373-84. PubMed ID: 21531442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses.
    Zanini S; Giovinazzo F; Alaimo D; Lawrence B; Pfragner R; Bassi C; Modlin I; Kidd M
    Cell Signal; 2015 May; 27(5):899-907. PubMed ID: 25701539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study.
    Jiang K; Cao F; Yin L; Hu Y; Zhao X; Huang X; Ma X; Li J; Lu M; Sun Y
    J Endocrinol Invest; 2024 May; 47(5):1251-1260. PubMed ID: 38060154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
    Klöppel G
    Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
    Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
    BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursor lesions of endocrine system neoplasms.
    Mete O; Asa SL
    Pathology; 2013 Apr; 45(3):316-30. PubMed ID: 23478233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine neoplasms of the esophagus and stomach.
    Mastracci L; Rindi G; Grillo F; Solcia E; Campora M; Fassan M; Parente P; Vanoli A; La Rosa S
    Pathologica; 2021 Feb; 113(1):5-11. PubMed ID: 33686305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis.
    Nie L; Li M; He X; Feng A; Wu H; Fan X
    Ann Diagn Pathol; 2016 Dec; 25():48-53. PubMed ID: 27806846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
    Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
    Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.
    Ramage JK; Valle JW; Nieveen van Dijkum EJM; Sundin A; Pascher A; Couvelard A; Kloeppel G; ;
    Neuroendocrinology; 2019; 108(1):45-53. PubMed ID: 30219817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
    Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.